Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Chinese Patent Office
Chubb
Citi
Federal Trade Commission

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 7,626,040

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,626,040
Title:Substituted imidazole compounds as KSP inhibitors
Abstract: The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula: ##STR00001##
Inventor(s): Barsanti; Paul A. (Moraga, CA), Xia; Yi (Palo Alto, CA), Wang; Weibo (Moraga, CA), Mendenhall; Kris G. (Concord, CA), Lagniton; Liana M. (Berkeley, CA), Ramurthy; Savithri (Walnut Creek, CA), Phillips; Megan C. (Walnut Creek, CA), Subramanian; Sharadha (San Ramon, CA), Boyce; Rustum (Singapore, SG), Brammeier; Nathan M. (Walnut Creek, CA), Constantine; Ryan (Oakland, CA), Duhl; David (Oakland, CA), Walter; Annette O. (Mill Valley, CA), Abrams; Tinya J. (Richmond, CA), Renhowe; Paul A. (Danville, CA)
Assignee: Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA)
Application Number:11/502,303
Patent Claims:see list of patent claims

Details for Patent 7,626,040

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-08-09 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-08-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Argus Health
McKinsey
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.